Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene

被引:15
|
作者
Divyakant, B. Patel [1 ]
Valay, R. Modi [1 ]
Alok, N. Thakkar [1 ]
Arpita, A. Patel [1 ]
Hetal, P. Thakkar [1 ]
机构
[1] Maharaja Sayajirao Univ Baroda, Fac Engn & Technol, Dept Pharm, Vadodara, Gujarat, India
来源
关键词
Drug entrapment; estrogen; solvent emulsification; zeta potential;
D O I
10.4103/0975-7406.94121
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temperature Solidification method showed the mean particle size, zeta potential and percentage drug entrapment of 101.4 +/- 3.5 nm, 19.4 +/- 0.279 mv, 97.67 +/- 1.02% respectively. The in-vitro intestinal permeability study indicated significantly higher permeation of the RSLNs than the marketed preparation. The in-vivo studies showed that pharmacokinetic parameters for the RSLNs were 3.5 times higher than the marketed preparation indicating significant increase in the oral bioavailability of the Raloxifene.
引用
收藏
页码:S14 / S16
页数:3
相关论文
共 50 条
  • [1] Evaluation of Oral Bioavailability and Anticancer Potential of Raloxifene Solid Lipid Nanoparticles
    Battani, Somashekhar
    Pawar, Harish
    Suresh, Sarasija
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (08) : 5638 - 5645
  • [2] Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles
    Varshosaz, Jaleh
    Minayian, Mohsen
    Moazen, Elaheh
    [J]. JOURNAL OF LIPOSOME RESEARCH, 2010, 20 (02) : 115 - 123
  • [3] Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability
    Kushwaha, Anand Kumar
    Vuddanda, Parameswara Rao
    Karunanidhi, Priyanka
    Singh, Sanjay Kumar
    Singh, Sanjay
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [4] Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
    Murthy, Aditya
    Ravi, Punna Rao
    Kathuria, Himanshu
    Malekar, Shrinivas
    [J]. NANOMATERIALS, 2020, 10 (06)
  • [5] Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles
    Yang, Li
    Geng, Yehui
    Li, Hao
    Zhang, Yu
    You, Jinsong
    Chang, Yanyan
    [J]. PHARMAZIE, 2009, 64 (02): : 86 - 89
  • [6] Formulation and Optimization of Raloxifene-Loaded Solid Lipid Nanoparticles to Enhance Oral Bioavailability
    Tran, Tuan Hiep
    Ramasamy, Thiruganesh
    Cho, Hyuk Jun
    Kim, Yong Il
    Poudel, Bijay Kumar
    Choi, Han-Gon
    Yong, Chul Soon
    Kim, Jong Oh
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (07) : 4820 - 4831
  • [7] Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles
    Silki
    Sinha, Vivek Ranjan
    [J]. AAPS PHARMSCITECH, 2018, 19 (03): : 1264 - 1273
  • [8] Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles
    Vivek Ranjan Silki
    [J]. AAPS PharmSciTech, 2018, 19 : 1264 - 1273
  • [9] Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide
    Goncalves, L. M. D.
    Maestrelli, F.
    Manelli, L. Di Cesare
    Ghelardini, C.
    Almeida, A. J.
    Mura, P.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 102 : 41 - 50
  • [10] Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study
    Shah, Nirmal V.
    Seth, Avinash K.
    Balaraman, R.
    Aundhia, Chintan J.
    Maheshwari, Rajesh A.
    Parmar, Ghanshyam R.
    [J]. JOURNAL OF ADVANCED RESEARCH, 2016, 7 (03) : 423 - 434